Triple

T17092999
Position Surface form Disambiguated ID Type / Status
Subject Ebolavirus E414769 entity
Predicate protein P112356 FINISHED
Object RNA-dependent RNA polymerase L
RNA-dependent RNA polymerase L is the large catalytic enzyme of Ebolavirus responsible for replicating and transcribing the viral RNA genome.
E1249840 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: RNA-dependent RNA polymerase L | Statement: [Ebolavirus, protein, RNA-dependent RNA polymerase L]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: RNA-dependent RNA polymerase L
Context triple: [Ebolavirus, protein, RNA-dependent RNA polymerase L]
  • A. HCV NS5B RNA-dependent RNA polymerase
    HCV NS5B RNA-dependent RNA polymerase is the viral enzyme in hepatitis C virus responsible for replicating its RNA genome and a key target for direct-acting antiviral drugs.
  • B. SARS-CoV-2 RNA-dependent RNA polymerase
    SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
  • C. HCV NS5A protein
    HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
  • D. Mastadenovirus
    Mastadenovirus is a genus of non-enveloped, double-stranded DNA viruses in the Adenoviridae family that infect mammals, including humans, and are associated with a range of respiratory, ocular, and gastrointestinal diseases.
  • E. RNA polymerase II
    RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: RNA-dependent RNA polymerase L
Triple: [Ebolavirus, protein, RNA-dependent RNA polymerase L]
Generated description
RNA-dependent RNA polymerase L is the large catalytic enzyme of Ebolavirus responsible for replicating and transcribing the viral RNA genome.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: RNA-dependent RNA polymerase L
Target entity description: RNA-dependent RNA polymerase L is the large catalytic enzyme of Ebolavirus responsible for replicating and transcribing the viral RNA genome.
  • A. HCV NS5B RNA-dependent RNA polymerase
    HCV NS5B RNA-dependent RNA polymerase is the viral enzyme in hepatitis C virus responsible for replicating its RNA genome and a key target for direct-acting antiviral drugs.
  • B. SARS-CoV-2 RNA-dependent RNA polymerase
    SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
  • C. HCV NS5A protein
    HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
  • D. Mastadenovirus
    Mastadenovirus is a genus of non-enveloped, double-stranded DNA viruses in the Adenoviridae family that infect mammals, including humans, and are associated with a range of respiratory, ocular, and gastrointestinal diseases.
  • E. RNA polymerase II
    RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886cfc8e88190b05ba466edd35591 completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3dbfabf548190a0d37bab3d4ef2fa completed April 18, 2026, 7:31 p.m.
NED1 Entity disambiguation (via context triple) batch_6a012eec0d5c8190806e756aae848ba2 completed May 11, 2026, 1:20 a.m.
NEDg Description generation batch_6a012f7f8b148190914b0d7cfb2d5c5c completed May 11, 2026, 1:23 a.m.
NED2 Entity disambiguation (via description) batch_6a012ffb67d4819099ec8d668cb590c9 completed May 11, 2026, 1:25 a.m.
Created at: April 10, 2026, 5:35 a.m.